Top Section/Ad
Top Section/Ad
Most recent
Sfr4.9bn trade is largest European ECM deal since National Grid’s £7bn rights issue in 2024
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
More articles/Ad
More articles/Ad
More articles
-
At-the-market transaction to take advantage of strong results despite volatile market -
Novo Nordisk bought £50m of the deal leaving £30m for the market
-
Flurry of deals in euros with more to come as Monday supply already beats last week’s total volume
-
Third step of Clariane's four-legged debt restructuring plan was 1.67 times oversubscribed
-
Evidence grows that companies can sell bonds successfully any day of the week
-
Valuation mismatch between issuer and investors prompted the decision to cancel the IPO
